Antiarrhythmic therapy following ablation of atrial fibrillation

References

• The AFFIRM Investigators. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation 109, 1509–1513 (2004).
   PubMed Web of Science ®Google Scholar
• Wazni OM, Marrouche NF, Martin DO et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA 293(21), 2634–2640 (2005).
   PubMed Web of Science ®Google Scholar
• Stabile G, Bertaglia E, Senatore G et al. Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study). Eur. Heart J. 27(2), 216–221 (2006).
   PubMed Web of Science ®Google Scholar
• Oral H, Pappone C, Chugh A et al. Circumferential pulmonary-vein ablation for chronic atrial fibrillation. N. Engl. J. Med. 354(9), 934–941 (2006).
   PubMed Web of Science ®Google Scholar
• Pappone C, Augello G, Sala S et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study. J. Am. Coll. Cardiol. 48(11), 2340–2347 (2006).
   PubMed Web of Science ®Google Scholar
• Jaïs P, Cauchemez B, Macle L et al. Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study. Circulation 118(24), 2498–2505 (2008).
   PubMed Web of Science ®Google Scholar
• Calkins H, Reynolds MR, Spector P et al. Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses. Circ. Arrhythm. Electrophysiol. 2(4), 349–361 (2009).
   PubMed Web of Science ®Google Scholar
• Bonanno C, Paccanaro M, La Vecchia L, Ometto R, Fontanelli A. Efficacy and safety of catheter ablation versus antiarrhythmic drugs for atrial fibrillation: a meta-analysis of randomized trials. J. Cardiovasc. Med. (Hagerstown) 11(6), 408–418 (2010).
   PubMed Web of Science ®Google Scholar
• Calkins H, Kuck KH, Cappato R et al. 2012 HRS/EHRA/ECAS Expert Consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace 14(4), 528–606 (2012).
   PubMed Web of Science ®Google Scholar
• Senatore G, Stabile G, Bertaglia E et al. Role of transtelephonic electrocardiographic monitoring in detecting short-term arrhythmia recurrences after radiofrequency ablation in patients with atrial fibrillation. J. Am. Coll. Cardiol. 45(6), 873–876 (2005).
   PubMed Web of Science ®Google Scholar
• Verma A, Kilicaslan F, Pisano E et al. Response of atrial fibrillation to pulmonary vein antrum isolation is directly related to resumption and delay of pulmonary vein conduction. Circulation 112(5), 627–635 (2005).
   PubMed Web of Science ®Google Scholar
• Rordorf R, Savastano S, Gandolfi E, Vicentini A, Petracci B, Landolina M. Pharmacological therapy following catheter ablation of atrial fibrillation. J. Cardiovasc. Med. (Hagerstown) 13(1), 9–15 (2012).
   PubMed Web of Science ®Google Scholar
• Turco P, De Simone A, La Rocca V et al. Antiarrhythmic drug therapy after radiofrequency catheter ablation in patients with atrial fibrillation. Pacing Clin. Electrophysiol. 30(Suppl. 1), S112–S115 (2007).
   PubMed Web of Science ®Google Scholar
• Roux JF, Zado E, Callans DJ et al. Antiarrhythmics After Ablation of Atrial Fibrillation (5A Study). Circulation 120(12), 1036–1040 (2009).
   PubMedGoogle Scholar
• Leong-Sit P, Roux JF, Zado E et al. Antiarrhythmics After Ablation of Atrial Fibrillation (5A Study): six-month follow-up study. Circ. Arrhythm. Electrophysiol. 4(1), 11–14 (2011).
   PubMed Web of Science ®Google Scholar
• Gu J, Liu X, Tan H et al. Extensive antiarrhythmic drugs after catheter ablation of persistent atrial fibrillation. Acta Cardiol. 67(4), 407–414 (2012).
   PubMed Web of Science ®Google Scholar
• Smit MD, Van Gelder IC. Upstream therapy of atrial fibrillation. Expert Rev. Cardiovasc. Ther. 7(7), 763–778 (2009).
   PubMedGoogle Scholar
• Richter B, Derntl M, Marx M, Lercher P, Gössinger HD. Therapy with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and statins: no effect on ablation outcome after ablation of atrial fibrillation. Am. Heart J. 153(1), 113–119 (2007).
   PubMed Web of Science ®Google Scholar
• Al Chekakie MO, Akar JG, Wang F et al. The effects of statins and renin–angiotensin system blockers on atrial fibrillation recurrence following antral pulmonary vein isolation. J. Cardiovasc. Electrophysiol. 18(9), 942–946 (2007).
   PubMed Web of Science ®Google Scholar
• Tayebjee MH, Creta A, Moder S et al. Impact of angiotensin-converting enzyme-inhibitors and angiotensin receptor blockers on long-term outcome of catheter ablation for atrial fibrillation. Europace 12(11), 1537–1542 (2010).
   PubMed Web of Science ®Google Scholar
• Shishehbor MH, Brennan ML, Aviles RJ et al. Statins promote potent systemic antioxidant effects through specific inflammatory pathways. Circulation 108(4), 426–431 (2003).
   PubMed Web of Science ®Google Scholar
• Suleiman M, Koestler C, Lerman A et al. Atorvastatin for prevention of atrial fibrillation recurrence following pulmonary vein isolation: a double-blind, placebo-controlled, randomized trial. Heart Rhythm 9(2), 172–178 (2012).
   PubMed Web of Science ®Google Scholar
• Goette A. Neutral effects of statins to prevent atrial fibrillation recurrences after catheter ablation of atrial fibrillation: should we bury upstream therapy for secondary prevention of atrial fibrillation? Heart Rhythm 9(2), 179–180 (2012).
   PubMed Web of Science ®Google Scholar
• Dentali F, Gianni M, Squizzato A et al. Use of statins and recurrence of atrial fibrillation after catheter ablation or electrical cardioversion. A systematic review and meta-analysis. Thromb. Haemost. 106(2), 363–370 (2011).
   PubMed Web of Science ®Google Scholar
• Koyama T, Sekiguchi Y, Tada H et al. Comparison of characteristics and significance of immediate versus early versus no recurrence of atrial fibrillation after catheter ablation. Am. J. Cardiol. 103(9), 1249–1254 (2009).
   PubMed Web of Science ®Google Scholar
• McCabe JM, Smith LM, Tseng ZH et al. Protracted CRP elevation after atrial fibrillation ablation. Pacing Clin. Electrophysiol. 31(9), 1146–1151 (2008).
   PubMed Web of Science ®Google Scholar
• Koyama T, Tada H, Sekiguchi Y et al. Prevention of atrial fibrillation recurrence with corticosteroids after radiofrequency catheter ablation: a randomized controlled trial. J. Am. Coll. Cardiol. 56(18), 1463–1472 (2010).
   PubMed Web of Science ®Google Scholar
• Ouyang F, Antz M, Ernst S et al. Recovered pulmonary vein conduction as a dominant factor for recurrent atrial tachyarrhythmias after complete circular isolation of the pulmonary veins: lessons from double Lasso technique. Circulation 111(2), 127–135 (2005).
   PubMed Web of Science ®Google Scholar
• Sholter DE, Armstrong PW. Adverse effects of corticosteroids on the cardiovascular system. Can. J. Cardiol. 16(4), 505–511 (2000).
   PubMed Web of Science ®Google Scholar
• Imazio M, Brucato A, Ferrazzi P et al.; COPPS Investigators. Colchicine reduces postoperative atrial fibrillation: results of the Colchicine for the Prevention of the Postpericardiotomy Syndrome (COPPS) atrial fibrillation substudy. Circulation 124(21), 2290–2295 (2011).
   PubMed Web of Science ®Google Scholar
• Deftereos S, Giannopoulos G, Kossyvakis C et al. Colchicine for prevention of early atrial fibrillation recurrence after pulmonary vein isolation: a randomized controlled study. J. Am. Coll. Cardiol. 60(18), 1790–1796 (2012).
   PubMed Web of Science ®Google Scholar
• Gerstenfeld EP, Callans DJ, Dixit S et al. Mechanisms of organized left atrial tachycardias occurring after pulmonary vein isolation. Circulation 110(11), 1351–1357 (2004).
   PubMed Web of Science ®Google Scholar
• Bertaglia E, Stabile G, Senatore G et al. Predictive value of early atrial tachyarrhythmias recurrence after circumferential anatomical pulmonary vein ablation. Pacing Clin. Electrophysiol. 28(5), 366–371 (2005).
   PubMed Web of Science ®Google Scholar
• Al-Khatib SM, Calkins H, Eloff BC et al. Developing the Safety of Atrial Fibrillation Ablation Registry Initiative (SAFARI) as a collaborative pan-stakeholder critical path registry model: a Cardiac Safety Research Consortium ‘Incubator’ Think Tank. Am. Heart J. 160(4), 619–626 (2010).
   PubMed Web of Science ®Google Scholar
• Arbelo E, Hindriks G, Maggioni A et al. Atrial Fibrillation Ablation Pilot Study: a new feature of the EURObservational Research Programme. Eur. Heart J. 32(10), 1173–1174 (2011).
   PubMed Web of Science ®Google Scholar